cetylpyridinium chloride anhydrous has been researched along with incretins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazakos, KA; Sarafidis, PA; Yovos, JG | 1 |
| Bergmayr, M; Göke, B; Herbach, N; Wanke, R; Wolf, E | 1 |
| Meier, JJ; Nauck, MA | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and incretins
| Article | Year |
|---|---|
Incretin hormones: Their role in health and disease.
Topics: Diabetes Mellitus, Type 2; Eating; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose; Health; Humans; Incretins; Insulin Secretion; Obesity; Weight Loss | 2018 |
1 trial(s) available for cetylpyridinium chloride anhydrous and incretins
| Article | Year |
|---|---|
The impact of diabetic autonomic neuropathy on the incretin effect.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Health; Humans; Incretins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male | 2008 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and incretins
| Article | Year |
|---|---|
Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Count; Cell Proliferation; Cell Separation; Cell Size; Cyclic AMP; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Health; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lipid Peroxidation; Mice; Mice, Transgenic; Organ Size; Oxidative Stress; Receptors, Gastrointestinal Hormone | 2011 |